OUTCOMES OF BTD VS BCD AS INITIAL TREATMENT OF RENAL AL AMYLOIDOSIS: A REAL-WORLD RETROSPECTIVE STUDY IN A CHINESE SINGLE CENTER

WCN23-0913
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
 
 
 
 
OUTCOMES OF BTD VS BCD AS INITIAL TREATMENT OF RENAL AL AMYLOIDOSIS: A REAL-WORLD RETROSPECTIVE STUDY IN A CHINESE SINGLE CENTER
Sheng, L.(1);Hok-Him , Y.(1);Jianteng , X.(1);Qiuling, L.(1);Yifan, Z.(1);Shaochun , L.(1);Pengjun , L.(2);Zekun , T.(3);Qiongwen , L.(4);Hongwen , F.(4);Hui , L.(3);Liwen, L.(4);Liye, Z.(2);Han, T.(1);Wenjian, W.(1)*;
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Guangdong Provincial People’S Hospital- Guangdong Academy Of Medical Sciences, Division Of Nephrology, Guangzhou, China;(2)Guangdong Provincial People’S Hospital- Guangdong Academy Of Medical Sciences, Division Of Hematopathology, Guangzhou, China;(3)Guangdong Provincial People’S Hospital- Guangdong Academy Of Medical Sciences, Division Of Radiology, Guangzhou, China;(4)Guangdong Provincial People’S Hospital- Guangdong Academy Of Medical Sciences, Division Of Cardiology, Guangzhou, China;
https://storage.unitedwebnetwork.com/files/1041/d7a6330de88398467bb2af805f4f2cb7.pdf
 
if any